Term ends Oct 13, 2035 · High confidence
Held by Amgen Inc.
Filed Apr 30, 2018 as application 29/645,873 · Granted Oct 13, 2020
Base term, 15 years from grant
Today
2020
2035
Clock starts
Oct 13, 2020
Oct 13, 2020
Term ends
Oct 13, 2035
Oct 13, 2035
base term
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
15 years from grant
Base term
No maintenance fees are payable on this kind of patent.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its base term, 15 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 15 years from grant | Granted Oct 13, 2020 | Oct 13, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Computed term end | The steps above, in order | Oct 13, 2035 | High confidence |
This family
| Application PCT/US2012/034535 | PCT application no patent term | no patent term |
| US 10,092,706 | In force Dec 2033 | Dec 2033 |
| US D808,010 | In force Jan 2033 | Jan 2033 |
| US D819,201 | In force May 2033 | May 2033 |
| US D829,890 | In force Oct 2033 | Oct 2033 |
| US D898,908 | this patent Oct 2035 | Oct 2035 |
| US 10,918,805 | In force no later than Nov 2032 | no later than Nov 2032 |
| US 11,419,990 | In force Mar 2033 | Mar 2033 |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 30, 2018 Reel 45670, frame 169 | Johnston, Neal; Ganzitti, Gabriele; Ewing, Kenneth R. | Flextronics Medical Sales and Marketing, Ltd. | Assignment of Assignor's Interest |
| Apr 30, 2018 Reel 45670, frame 54 | Denzer, Michael; Swift, Robert W.; Krishna, Suhas | Amgen Inc. | Assignment of Assignor's Interest |
| Apr 30, 2018 Reel 45670, frame 341 | Flextronics Medical Sales and Marketing, Ltd. | Amgen Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center
No maintenance fees are payable on this kind of patent, so the record carries no fee events.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2035
Term ends Oct 13, 2035. No maintenance fees are payable on this kind of patent
Citations
22
later US patents cite this one
That is top 25% of design patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.